CLG LLC’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$669K Sell
2,528
-44
-2% -$11.6K 0.14% 72
2026
Q2
$653K Sell
2,572
-223
-8% -$52K 0.14% 82
2026
Q1
$683K Buy
2,795
+36
+1% +$8.38K 0.17% 71
2025
Q4
$571K Buy
2,759
+2
+0.1% +$395 0.14% 82
2025
Q3
$511K Buy
2,757
+30
+1% +$5.14K 0.14% 85
2025
Q2
$417K Sell
2,727
-17
-0.6% -$2.61K 0.13% 89
2025
Q1
$455K Buy
2,744
+4
+0.1% +$626 0.16% 78
2024
Q4
$396K Buy
+2,740
New +$425K 0.14% 82

Other funds holding JNJ

CLG LLC's JNJ Position: Q3 2026 in Review

CLG LLC reduced its Johnson & Johnson (JNJ) stake by 1.7% in Q3 2026, selling an estimated $11.6K and leaving 2,528 shares worth $669K. The position accounts for 0.14% of the portfolio, ranked #72.

CLG LLC first reported a position in JNJ in Q4 2024 and has held it in 8 quarters since. The position peaked at $683K in Q1 2026. 1,611 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • CLG LLC held 2,528 shares of Johnson & Johnson worth $669K as of Q3 2026.
  • CLG LLC sold 44 Johnson & Johnson shares in Q3 2026, an estimated $11.6K.
  • Johnson & Johnson made up 0.14% of CLG LLC's portfolio in Q3 2026, its #72 holding.
  • CLG LLC first reported a position in Johnson & Johnson in Q4 2024 and has held it in 8 quarters since.
  • CLG LLC's Johnson & Johnson position peaked at $683K in Q1 2026.
  • 1,611 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on CLG LLC's 13F filing for Q3 2026, filed 13 Oct 2026.